Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Assets Average (2016 - 2026)

Catalyst Pharmaceuticals filings provide 16 years of Assets Average readings, the most recent being $1.1 billion for Q1 2026.

  • On a quarterly basis, Assets Average rose 27.91% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 27.91% increase, with the full-year FY2025 number at $977.7 million, up 47.96% from a year prior.
  • Assets Average hit $1.1 billion in Q1 2026 for Catalyst Pharmaceuticals, up from $1.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2026 to a low of $242.4 million in Q1 2022.
  • Median Assets Average over the past 5 years was $558.4 million (2024), compared with a mean of $627.2 million.
  • Biggest five-year swings in Assets Average: increased 24.43% in 2022 and later skyrocketed 83.79% in 2024.
  • Catalyst Pharmaceuticals' Assets Average stood at $354.4 million in 2022, then rose by 24.63% to $441.7 million in 2023, then surged by 83.79% to $811.7 million in 2024, then skyrocketed by 32.78% to $1.1 billion in 2025, then grew by 4.45% to $1.1 billion in 2026.
  • The last three reported values for Assets Average were $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025) per Business Quant data.